CS Paper Radar

Large Language Model Agents for Evidence Based Genetic Disease Severity Classification

Tohid Ghasemnejad, Ahmadreza Argha, Mark Grosser, John Wang, Min Yang, Thantrira Porntaveetus, Tony Roscioli, Nigel H. Lovell, Mahmoud Aarabi, Hamid Alinejad-Rokny

cs.AI q-bio.GNcs.CL ·submitted 2026-09-17 01:56 UTC · v2

Abstract

Disease severity classification for genetic conditions is subjective and labor-intensive, creating bottlenecks in genomic screening, where commercial panels vary widely in size and overlap. We developed an autonomous AI agent integrating Reasoning and Acting (ReAct) with Retrieval-Augmented Generation (RAG) to classify 10,211 Human Phenotype Ontology terms. It uses American College of Medical Genetics (ACMG)-endorsed severity guidelines and American College of Obstetricians and Gynecologists (ACOG) quality-of-life criteria to retrieve PubMed literature, generate interpretable reasoning chains, and independently verify claims. At the phenotype level, using expert-curated cohorts, the agent achieved 93.55% accuracy (MCC 0.9237) with 82.6% to 91.4% of claims supported by direct evidence or valid inferences. Gene-level severity was aggregated across 8,738 pairs, identifying 3,283 autosomal recessive pairs with severe or profound presentations. External validation showed 95.2% concordance with Mackenzie's Mission gene list. This system enables standardized panel design by providing reliable, automated classification supported by direct evidence.

Closest papers

Nearest neighbours by meaning across the whole index.

A Semantic Model of Genetic Evidence: A Step Toward Bridging the Basic-Science-Clinic Gap

cs.DB cs.AIq-bio.GN ·2026-09-03 ·Michael Bouzinier, Dmitry Etin
benchmarkpositioncode/data similarity 0.71
Abstract · 16 pages; supplementary material (32 pages) included in this submission. Schema, annotations, and code: https://github.com/ForomePlatform/ge…

Scientific and clinical decision-making depends on evidence from the primary literature, but existing standards for representing that evidence (FHIR Evidence, ECO, SEPIO, and the GA4GH Genomic Knowledge Standards) are oriented toward clinical-trial workflows, evidence codes, or single-variant assertions, and do not capture the fine-grained, domain-specific structure of claims in basic and pre-clinical research. We introduce a semantic model for scientific evidence with three core classes, specialize it for genetics, align it structurally to FHIR Evidence with a SEPIO-anchored credibility decomposition, and attach a compact dimensional vocabulary whose conditional-activation rules are validated by a SHACL schema for the implemented constraints. Using clinical variant interpretation as the driving use case, we evaluate the model through a human-AI annotation pilot over six genetics papers, yielding 28 evidence items and 95 source-anchored assertions, with a workflow that keeps curator-authored reference annotations distinct from AI-drafted annotations. Treating the pilot as a feasibility study rather than a benchmark, we argue that the model is a useful increment toward trustworthy, AI-ready infrastructure for variant interpretation: a reference data model and validation schema for representing genetic evidence.

0.31

Advancing Clinical Genomic Analysis with a Skill-Centred Agent

cs.AI q-bio.GN ·2026-10-29 ·Qiaoyu Zheng, Weike Zhao, Yanjie Fan, Ye Cao, Mengqi Jiang +8 more
benchmark similarity 0.70
Abstract

Clinical genomic analysis requires experts to integrate evolving guidelines, databases, and computational evidence. As sequencing has become increasingly accessible, this complex and labor-intensive process has become a major bottleneck to the timely use of genomic information in clinical decision-making. To fill this gap, we developed ClinGeX, a large-language-model agent that composes 105 curated executable skills through task-specific retrieval and dependency-aware orchestration. On 223 temporally held-out benchmark cases, ClinGeX achieved 71.7\% macro-averaged task-level concordance with expert reference classifications, compared with 45.7\% for the strongest comparator. In a three-condition, counterbalanced human-AI collaboration study, 45 clinical genomic professionals assessed 135 clinically derived cases under routine (no AI assistance), DeepSeek-assisted and ClinGeX-assisted conditions. ClinGeX assistance increased raw case-level concordance across criterion-level variant analysis, genomic interpretation in rare disease and molecular oncology decision-making (51.1\%, 57.8\%, 64.4\% versus 15.6\%, 31.1\%, 20.0\% in comparator conditions) and reduced reported interpretation time in all scenarios. During an exploratory one-month real-world non-interventional assessment, 11 experienced professionals submitted feedback on 96 self-selected analysis episodes and reported frequent conclusion adoption and time savings. These findings support executable domain skills as a promising approach to augment specialist genomic interpretation.

0.23

Generating Biomedical Fact-Checking Reports with RL-Enhanced Agentic Search

cs.AI ·2026-08-24 ·Jiongxiao Wang, Dingli Ma, Chaoqun Ni
code/data similarity 0.67
Abstract

Automated fact-checking is essential for ensuring the reliability of public health information, yet the biomedical domain poses unique challenges. Validating biomedical claims requires rigorous interpretation of scientific literature, assessment of retrieved evidence, and comprehensive justification toward the conclusion. Although Large Language Models (LLMs) enhanced by Retrieval-Augmented Generation (RAG) and agentic search perform automated fact-checking in a retrieve-then-verify paradigm, current methods still output isolated prediction labels, lacking explanatory depth and offers limited utility for human understanding. To bridge this gap, we introduce an LLM-based agent named BioCheck Agent that generates structured biomedical fact-checking reports with agentic search. Rather than merely outputting supported or refuted labels, our agent synthesizes final conclusions with retrieved evidence and rigorous analysis. To ensure domain-specific accuracy, BioCheck Agent exclusively searches high-quality scientific literature in PubMed, utilizing advanced Boolean search operators. Recognizing that direct prompting often results in hallucinations and low-quality reports, especially for lightweight open-source models, we further propose the Evidence-Grounded Group Relative Policy Optimization (EG-GRPO) to perform reinforcement learning on BioCheck Agent with a task-specific reward that incentivizes advanced search behavior and high-quality evidence retrieval while penalizing hallucinations. Our experimental results show that compared to the base model Qwen3.5-4B, BioCheck Agent with EG-GRPO improves label prediction accuracy on SciFact by 9.95%. Furthermore, it achieves a 3.7% higher evidence quality score and a 19.63% lower evidence hallucination rate, demonstrating its ability to generate biomedical fact-checking reports with improved accuracy and quality.

0.32

Ascent: An Agentic System over the Model Context Protocol for Real-World Clinical Data Analysis

cs.AI cs.IR ·2026-09-21 ·Angelo Ziletti, Leonardo D'Ambrosi, Melanie Tuchardt, Tim Kondziella
dataset similarity 0.67
Abstract

Answering epidemiological questions from real-world clinical data requires medical coding, schema-aware SQL, and validation of implicit choices about populations, denominators, and time. We present Ascent, an agentic system that exposes medical coding, question answering, and cohort analysis through a shared Model Context Protocol tool surface for standardized and native schemas. We introduce EpiTrap, a dataset testing whether systems avoid recognized pharmacoepidemiological errors, and compare a fixed pipeline with agents across models and orchestrators. With capable models, agents improve accuracy over the fixed pipeline by an average of 27 and 20 percentage points on native and standardized schemas, respectively. These gains require more tool calls and longer runtimes. Experience from real projects highlights the system's value for feasibility assessment, diagnostic iteration, and expert-guided analysis.

0.06

ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents

cs.AI cs.MA ·2026-10-26 ·Sirry Chen, Fangke Chen, Xuanwen Ding, Wei Chen, Zhongyu Wei
similarity 0.65
Abstract

Disease diagnosis is a key application of large language model (LLM) agents in healthcare. However, existing medical agents are primarily trained and evaluated with static question-answering data, providing limited opportunities to learn active information acquisition, examination decision-making, and dynamic clinical interaction. To address this limitation, we present ClinVerse, an interactive, real-data-grounded multi-agent environment designed for training and evaluating medical diagnostic agents. Built on ClinPatient, a scalable dataset comprising 150k diagnostic cases derived from real-world electronic health records, ClinVerse supports coordinated interactions among six specialized clinical roles. Specifically, a doctor agent starts from an initial patient complaint, progressively gathers clinical evidence through patient interviews and examination requests, and ultimately produces a diagnosis. For each interaction trajectory, a rule-based scoring framework quantifies information acquisition, examination ordering, and diagnostic accuracy. These trajectory-level scores serve as reward signals for agent training while also enabling scalable evaluation. In experiments, we evaluate various general-purpose and medical-domain models and show that nine self-evolution methods across three categories consistently improve agents' diagnostic capabilities within ClinVerse. We further analyze the interplay among model capability, environment feedback, and self-evolution methods.

0.13

HPOQuest: A Rare-Disease Diagnostic Agent Using Active Phenotype Acquisition

cs.AI cs.LGq-bio.GN ·2026-09-16 ·Kamilia Zaripova, Nassir Navab, Azade Farshad, Annalisa Marsico
benchmark similarity 0.64
Abstract

More than 300 million people worldwide are affected by one of over 7,000 known rare diseases, yet diagnosis remains difficult because patients initially present with incomplete and heterogeneous phenotypes. We present HPOQuest, a training-free framework for sequential phenotype acquisition in rare-disease diagnosis. Starting from a small set of observed patient phenotypes, HPOQuest maintains a probabilistic disease ranking and iteratively selects informative follow-up questions to support clinicians during patient assessment. Confirmed phenotypes update the disease ranking, while all responses update the candidate question set. Across four benchmark cohorts, HPOQuest substantially improves diagnosis from sparse initial phenotypes, with gains of up to 30% points at Recall@1 and 45% points at Recall@5. These results demonstrate that sequential phenotype acquisition can substantially improve rare-disease diagnosis from limited initial clinical evidence.

0.24

Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis

cs.AI ·2026-10-24 ·Jian Yang, Peilin Liu, Xiaohan Li, Songda Li, Yu Cao +2 more
benchmark similarity 0.64
Abstract · 18 page, 3 figures

Augmented large language model (LLM) systems have reported high benchmark accuracies in rare disease diagnosis, yet their real-world clinical utility remains unproven. A recent meta-analysis flagged augmented LLM diagnostic evaluations as having a high risk of bias due to suspected data leakage; however, the precise impact of these vulnerabilities on model inference has yet to be fully quantified. In this study, we present a comprehensive empirical audit to quantify evaluation artifacts across prevailing AI paradigms, using a repository of over 60,000 cases from diverse public and independent clinical cohorts. By reconstructing a state-of-the-art agentic framework, we demonstrate that candidate-space contamination artificially inflates performance: enforcing strict cross-dataset isolation resulted in a marked performance decline, with the cross-dataset mean Recall@1 decreasing from 54.3% (under conventional one-vs-rest evaluation) to 40.3% (Hedges' g = 0.94). Similar spatial overfitting in supervised classifiers caused diagnostic accuracy to drop from an internal mean of 42.9% to 16.7% across external cohorts (Cohen's d = 2.01). Furthermore, we quantify how LLMs infer diagnoses by exploiting retrospective therapeutic cues in clinical narratives, and how temporal misalignment in foundational knowledge bases leads to performance fluctuations. We conclude that prevailing evaluation protocols for augmented LLM systems inadvertently reflect data leakage rather than genuine medical reasoning. To address these systematic artifacts, we propose a rigorous evaluation framework - coupling strict data-isolation protocols with standardized benchmarking safeguards - to ensure future diagnostic AI for rare diseases is evaluated on actual clinical robustness.

0.50

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.64
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25